(Q39477447)

12 September 2017

Effect of RNAi-induced down regulation of nuclear factor kappa-B p65 on acute monocytic leukemia THP-1 cells in vitro and vivo (English)

1 reference

12 September 2017

1 reference

acute monocytic leukemia

1 reference

Chunmei Wang

1

1 reference

12 September 2017

Guangyao Sheng

2

1 reference

12 September 2017

Jie Lu

3

1 reference

12 September 2017

Lei Xie

4

1 reference

12 September 2017

Songting Bai

5

1 reference

12 September 2017

Yingchao Wang

6

1 reference

12 September 2017

Yufeng Liu

7

1 reference

12 September 2017

language of work or name

1 reference

7 September 2011

1 reference

Molecular and Cellular Biochemistry

12 September 2017

1 reference

12 September 2017

359

1 reference

12 September 2017

1-2

1 reference

12 September 2017

125-133

1 reference

https://scigraph.springernature.com/pub.10.1007/s11010-011-1006-z

12 September 2017

0 references

cites work

Acute monocytic leukemia: a single institution experience.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1006-Z

Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1006-Z

Successive clinical trials for childhood acute myeloid leukemia at St Jude Children's Research Hospital, from 1980 to 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1006-Z

Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1006-Z

Long-term results of children with acute myeloid leukemia: a report of three consecutive Phase III trials by the Children's Cancer Group: CCG 251, CCG 213 and CCG 2891.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1006-Z

Risk factors and therapy for isolated central nervous system relapse of pediatric acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1006-Z

Nuclear factor-kappaB: the enemy within

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1006-Z

Expression of tyrosine kinase Etk/Bmx and its relationship with AP-1- and NF-kappaB-associated proteins in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1006-Z

Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1006-Z

NF-kappa B genes have a major role in inflammatory breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1006-Z

RNAi-based therapeutics-current status, challenges and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1006-Z

Double transfection improves small interfering RNA-induced thrombin receptor (PAR-1) gene silencing in DU 145 prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1006-Z

Combined effects of cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1006-Z

21 January 2018

Signaling to NF-kappaB

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1006-Z

A c-Rel subdomain responsible for enhanced DNA-binding affinity and selective gene activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1006-Z

Transcriptional regulation via the NF-kappaB signaling module.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1006-Z

Distinctions between c-Rel and other NF-kappaB proteins in immunity and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1006-Z

NF-kappaB inhibition triggers death of imatinib-sensitive and imatinib-resistant chronic myeloid leukemia cells including T315I Bcr-Abl mutants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1006-Z

An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1006-Z

Involvement of the p65/RelA subunit of NF-kappaB in TNF-alpha-induced SIRT1 expression in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1006-Z

Construction of NF-κB-targeting RNAi adenovirus vector and the effect of NF-κB pathway on proliferation and apoptosis of vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1006-Z

NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1006-Z

NF-kB in development and progression of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1006-Z

Loss of the SMRT/NCoR2 corepressor correlates with JAG2 overexpression in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1006-Z

The prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor NCOR2/SMRT is an independent indicator of poor outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1006-Z

Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-1006-Z

Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab

21 January 2018

1 reference

12 December 2020

Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.

1 reference

12 December 2020

Suppression of heart NF-κB p65 expression by jugular vein injection of RNAi in mice

1 reference

12 December 2020

Long-term survival in acute myeloid leukemia: the Eastern Cooperative Oncology Group experience.

1 reference

12 December 2020

[Influence of inhibitory KappaB protein kinase alpha and gamma genes silencing induced by RNA interference on nuclear factor-KappaB signal pathway]

1 reference

12 December 2020

Transcription factor co-repressors in cancer biology: roles and targeting

1 reference

12 December 2020

Transactivation domain 2 (TA2) of p65 NF-kappa B. Similarity to TA1 and phorbol ester-stimulated activity and phosphorylation in intact cells

1 reference

12 December 2020

Expression of NF-kappaB and COX-2 in young versus older patients with sporadic colorectal cancer

1 reference

12 December 2020

The effect of NF-κB pathway on proliferation and apoptosis of human umbilical vein endothelial cells induced by intermittent high glucose

1 reference

12 December 2020

Expression of nuclear factor kappaB in human gastric carcinoma: relationship with I kappaB a and prognostic significance

1 reference

12 December 2020

10.1007/S11010-011-1006-Z

Identifiers

DOI

1 reference

12 September 2017

1 reference